Belite Bio (BLTE) Institutional Ownership $64.50 -2.44 (-3.65%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)CurrentInstitutional OwnershipPercentage0.53%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$8.70MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$470.86K Get BLTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLTE Institutional Buying and Selling by Quarter Remove Ads Belite Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC5,211$329K0.0%-19.3%0.017% 2/17/2025 Bank of America Corp DE18,342$1.16M0.0%+36.4%0.059% 2/17/2025 BNP Paribas Financial Markets2,450$155K0.0%N/A0.008% 2/14/2025 Virtus ETF Advisers LLC1,122$71K0.0%-39.1%0.004% 2/13/2025 Marshall Wace LLP5,865$370K0.0%-30.9%0.018% 2/13/2025 XTX Topco Ltd7,062$446K0.0%+30.9%0.022% 2/12/2025 JPMorgan Chase & Co.14,636$924K0.0%+130.3%0.047% 1/28/2025 Advisors Preferred LLC798$52K0.0%N/A0.003% 1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004% 12/26/2024 JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021% 11/15/2024 XTX Topco Ltd5,394$253K0.0%N/A0.018% 11/15/2024 State Street Corp20,086$942K0.0%+28.2%0.066% 11/15/2024 Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016% 10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003% 8/19/2024 Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025% 8/15/2024 Armistice Capital LLC148,000$6.76M0.1%N/A0.497% 2/13/2024 Armistice Capital LLC36,000$1.65M0.0%N/A0.130% 2/7/2024 Jump Financial LLC5,200$238K0.0%N/A0.019% 11/8/2023 Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272% 8/3/2023 Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268% 2/13/2023 Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264% 11/3/2022 Barclays PLC6,661$223K0.0%N/A0.027% 8/15/2022 Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199% (Data available from 1/1/2016 forward)Remove Ads BLTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLTE shares? During the previous two years, 14 institutional investors and hedge funds held shares of Belite Bio. The most heavily invested institutionals were Armistice Capital LLC ($6.76M), Atria Wealth Solutions Inc. ($2.36M), Bank of America Corp DE ($1.16M), State Street Corp ($942K), JPMorgan Chase & Co. ($924K), XTX Topco Ltd ($446K), and Marshall Wace LLP ($370K).Learn more on BLTE's institutional investors. What percentage of Belite Bio stock is owned by institutional investors? 0.53% of Belite Bio stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings. Which institutional investors have been buying Belite Bio stock? Of the 10 institutional investors that purchased Belite Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($184K), JPMorgan Chase & Co. ($14.55K), XTX Topco Ltd ($7.06K), Jump Financial LLC ($5.20K), Bank of America Corp DE ($4.89K), State Street Corp ($4.42K), and Atria Wealth Solutions Inc. ($2.73K). How much institutional buying is happening at Belite Bio? Institutional investors have bought a total of 226,959 shares in the last 24 months. This purchase volume represents approximately $10.63M in transactions. Which Belite Bio major shareholders have been selling company stock? The following institutional investors have sold Belite Bio stock in the last 24 months: Atria Wealth Solutions Inc. ($740.48K), Point72 Asset Management L.P. ($3.90K), Marshall Wace LLP ($2.62K), Citadel Advisors LLC ($1.25K), and Virtus ETF Advisers LLC ($721.00). How much institutional selling is happening at Belite Bio? Institutional investors have sold a total of 748,970 shares in the last 24 months. This volume of shares sold represents approximately $24.06M in transactions. Related Companies ROIV Major Shareholders RVMD Major Shareholders LNTH Major Shareholders LEGN Major Shareholders TGTX Major Shareholders BBIO Major Shareholders AXSM Major Shareholders BPMC Major Shareholders GRFS Major Shareholders NUVL Major Shareholders This page (NASDAQ:BLTE) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.